ICAM1 and COVID-19: We also found an increased expression of CD63, ITGB2, CD37, CD2 and IL23R markers and the reduction in CXCR4, CD69, CD48, ICAM1 and S100A10 markers in COVID-19-derived NK-T cells compared to controls (Figure 4D).